BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29311096)

  • 1. Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT.
    Berger G; Kroeze LI; Koorenhof-Scheele TN; de Graaf AO; Yoshida K; Ueno H; Shiraishi Y; Miyano S; van den Berg E; Schepers H; van der Reijden BA; Ogawa S; Vellenga E; Jansen JH
    Blood; 2018 Apr; 131(16):1846-1857. PubMed ID: 29311096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
    Soerensen JF; Aggerholm A; Rosenberg CA; Bill M; Kerndrup GB; Ebbesen LH; Hansen MH; Roug AS; Ludvigsen M
    Bone Marrow Transplant; 2022 Mar; 57(3):460-465. PubMed ID: 35027675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
    Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
    J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
    Soerensen JF; Aggerholm A; Kerndrup GB; Hansen MC; Ewald IKL; Bill M; Ebbesen LH; Rosenberg CA; Hokland P; Ludvigsen M; Stidsholt Roug A
    Blood Adv; 2020 Mar; 4(5):885-892. PubMed ID: 32150606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related myeloid neoplasms: what's in a name?
    Klimek VM; Tray NJ
    Curr Opin Hematol; 2016 Mar; 23(2):161-6. PubMed ID: 26779614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of acquired cytogenetic clones in patients with treated follicular lymphoma.
    Wang XI; Yin CC; Qazilbash MH; Hu S; Lu G
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):262-9. PubMed ID: 25573378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia.
    Hartmann L; Nadarajah N; Meggendorfer M; Höllein A; Vetro C; Kern W; Haferlach T; Haferlach C; Stengel A
    Leukemia; 2020 Mar; 34(3):811-820. PubMed ID: 31719678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
    Diamond B; Ziccheddu B; Maclachlan K; Taylor J; Boyle E; Ossa JA; Jahn J; Affer M; Totiger TM; Coffey D; Chandhok N; Watts J; Cimmino L; Lu SX; Bolli N; Bolton K; Landau H; Park JH; Ganesh K; McPherson A; Sekeres MA; Lesokhin A; Chung DJ; Zhang Y; Ho C; Roshal M; Tyner J; Nimer S; Papaemmanuil E; Usmani S; Morgan G; Landgren O; Maura F
    Blood; 2023 May; 141(19):2359-2371. PubMed ID: 36626250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer.
    Nichols G; de Castro K; Wei LX; Griffin M; Lin N; Oratzi A; Murty VV; Troxel A; Vahdat L; Hesdorffer C
    Leukemia; 2002 Sep; 16(9):1673-9. PubMed ID: 12200680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
    Miller LH; Qu CK; Pauly M
    Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer.
    Epstein-Peterson ZD; Devlin SM; Stein EM; Klimek VM; Saltz LB; Tallman MS
    Leuk Res; 2019 Jul; 82():19-23. PubMed ID: 31151028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure.
    Pedersen-Bjergaard J; Pedersen M; Myhre J; Geisler C
    Leukemia; 1997 Oct; 11(10):1654-60. PubMed ID: 9324285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Jaimes-Albornoz D; Mannone L; Nguyen-Quoc S; Chalandon Y; Chevallier P; Mohty M; Meunier M; Robin M; Ledoux MP; Guillerm G; Bay JO; Poiré X; Maillard N; Leclerc M; Daguindau E; Beguin Y; Rubio MT; Gyan E
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2366-2374. PubMed ID: 31326611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Smeets MF; Tan SY; Xu JJ; Anande G; Unnikrishnan A; Chalk AM; Taylor SR; Pimanda JE; Wall M; Purton LE; Walkley CR
    Blood; 2018 Aug; 132(6):608-621. PubMed ID: 29903888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.